Národný onkologický ústav v Bratislave

Clement What the numbers say about this buyer

• 53% of this buyer's awards went to companies that had already won here before (99 awards since 2024, spread over 46 companies). That is well above the national norm (31%) — newcomers have a harder time here than elsewhere.n = 99 awards since 2024
• The median procedure drew 3 bids (98 procedures with a bid count); 22% ended with a single bidder. Country: median 2.5 bids.n = 98
• The award came in at a median 88% of the estimated value (41 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 85%.n = 41
• 79% of the bids received came from small and medium-sized enterprises (98 procedures with a bid mix). Country: 89%.n = 98
• 21% of awards went to companies from abroad (99 awards with a known winner country). National average: 20%.n = 99
• 1% of the bids received came from other countries (98 procedures with a bid mix) — all bidders, not just the winners. Country: 3%.n = 98

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 28/10/2026.